Search
Piperine
go.drugbank.com/drugs/DB12582InvestigationalBioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesPhenamazoline
go.drugbank.com/drugs/DB19509ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Phenamazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Tinazoline
go.drugbank.com/drugs/DB20310ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Tinazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Nemazoline
go.drugbank.com/drugs/DB21115ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Urelumab
go.drugbank.com/drugs/DB12077InvestigationalThe antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with
Ontuxizumab
go.drugbank.com/drugs/DB16270InvestigationalOntuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1).
Mentha arvensis top
go.drugbank.com/drugs/DB14346InvestigationalMentha arvensis top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Corn Mint Top, Field Mint TopEpimedium grandiflorum top
go.drugbank.com/drugs/DB14301InvestigationalEpimedium grandiflorum top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Barrenwort Top, Epimedium grandiflorum topIspronicline
go.drugbank.com/drugs/DB16205InvestigationalIspronicline is under investigation in clinical trial NCT00109564 (A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)).
Plamotamab
go.drugbank.com/drugs/DB18944InvestigationalPlamotamab is under investigation in clinical trial NCT05328102 (Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (